Resource Logo
AIDS Treatment Data Network

HCV/HIV Co-infection Treatments




 

Information Bulletin #14 - March 2002

If you would like more information about HCV and HIV co-infection, and HCV treatment options, you can contact The Network at (800) 734-7104 or (212) 260-8868. A lot of new information regarding co-infection and the hepatitis C virus is becoming available. For example, a recent study showed that people who are HCV co-infected are more likely to experience liver toxicity from the drug nevirapine (Viramune) than HIV-positive people who are not infected with HCV. Protease inhibitors also seem to have more potential to cause liver damage in people who are co-infected. Several very important studies concerning HIV/HCV co-infection and treatment, as well as new information regarding lactic acidosis and mitochondrial toxicity, will be available very shortly as well.

Interested individuals who live in New York City, or receive HIV services of some type in New York are encouraged to contact us regarding our HIV/HCV education, treatment adherence, and counseling program. We will send you a full description of the program, and how it could help HIV-positive individuals to pay for both HIV and HCV treatments, as well as experimental treatment programs. The program also offers supportive counseling to co-infected individuals. Give us a call or e-mail to network@atdn.org.



 


Copyright © 2002 -AIDS Treatment Data Network, Publisher. All rights reserved to AIDS Treatment Data Network. Reproduction of this article (other than one copy for personal reference) must be cleared through the AIDS Treatment Data Network. Email AIDS Treatment Data Network

Information in this article was accurate in March 10, 2002. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.